Skip to main content

Table 1 Baseline characteristics of two groups

From: Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer

Characteristics Treatment group Control group P value
Number 21 61  
Age (years)    
 Mean (Range) 56.6 (32–74) 56.4 (31–74) 0.95
Gender    
 Male 19 (90.5 %) 53 (86.9 %)  
 Female 2 (9.5 %) 8 (13.1 %) 0.73
Clinical stage    
 III 10 (47.6 %) 37 (60.7 %)  
 IV 11 (52.4 %) 24 (39.3 %) 0.30
Tumor histology    
 Adenocarcinoma 8 (38.1 %) 26 (42.6 %)  
 Squamous carcinoma 13 (61.9 %) 35 (57.4 %) 0.72
Cycles of previous chemotherapy 2.9 ± 0.7 3.1 ± 0.8 0.53
PS score 0.4 ± 0.6 0.6 ± 0.7 0.35